Literature DB >> 15505003

Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection.

Albert Lecube1, Cristina Hernández, Joan Genescà, Joan I Esteban, Rosend Jardí, Lydia García, Rafael Simó.   

Abstract

OBJECTIVE: A high prevalence of diabetes has been reported in patients with hepatitis C virus (HCV) infection. Both diabetes and HCV infection are associated with high serum ferritin levels. Although HCV infection could be the main factor responsible for the high ferritin levels, it is also possible that diabetes rather than HCV infection might be a major contributor to the high ferritin levels observed in patients with HCV infection. The aim of this study was to investigate the contribution of diabetes to the high ferritin levels observed in HCV-infected patients with chronic hepatitis. RESEARCH DESIGN AND METHODS: A total of 634 noncirrhotic individuals were prospectively recruited at a university hospital. According to the HCV antibody status and the presence of diabetes, the subjects were divided into four groups: group A (anti-HCV-positive diabetic patients, n = 53), group B (anti-HCV-negative diabetic patients, n = 242), group C (anti-HCV-positive nondiabetic patients, n = 191), and group D (anti-HCV-negative nondiabetic control subjects, n = 148). Multiple regression analyses were used to explore the variables independently related to ferritin levels.
RESULTS: Serum ferritin levels in group A were significantly higher than in the other groups (A > B, P < 0.01; A > C, P < 0.001; A > D, P < 0.001). Ferritin levels were higher in group B than in group D (P = 0.001). However, group C has ferritin values similar to those of group D. In multivariate analyses, diabetes but not HCV infection was independently related to serum ferritin concentrations.
CONCLUSIONS: Diabetes rather than HCV infection itself is the main factor associated with the increased ferritin levels detected in patients with HCV infection. Therefore, the presence of diabetes should be taken into account when iron metabolism is evaluated in HCV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505003     DOI: 10.2337/diacare.27.11.2669

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

1.  Serum ferritin-a novel risk factor in acute myocardial infarction.

Authors:  M P Holay; A A Choudhary; S D Suryawanshi
Journal:  Indian Heart J       Date:  2012-04-28

2.  The Role of Insulin Therapy in Correcting Hepcidin Levels in Patients with Type 2 Diabetes Mellitus.

Authors:  Driton Vela; Jovica Leshoski; Elizabeta S Gjorgievska; Nikola Hadzi-Petrushev; Muharrem Jakupaj; Ramadan B Sopi; Mitko Mladenov
Journal:  Oman Med J       Date:  2017-05

3.  Effects of Cardiorespiratory Fitness on Serum Ferritin Concentration and Incidence of Type 2 Diabetes: Evidence from the Aerobics Center Longitudinal Study (ACLS).

Authors:  Tuan D Le; Sejong Bae; Chiehwen Ed Hsu; Karan P Singh; Steven N Blair; Ning Shang
Journal:  Rev Diabet Stud       Date:  2009-02-10

Review 4.  Molecular mechanisms of insulin resistance in chronic hepatitis C.

Authors:  Mark W Douglas; Jacob George
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

Review 5.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

6.  Hyperferritinemia is a risk factor for steatosis in chronic liver disease.

Authors:  Anna Licata; Maria Elena Nebbia; Giuseppe Cabibbo; Giovanna Lo Iacono; Francesco Barbaria; Virna Brucato; Nicola Alessi; Salvatore Porrovecchio; Vito Di Marco; Antonio Craxì; Calogero Cammà
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

7.  Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.

Authors:  Simple Bhadania; Neena Bhalodiya; Yashendra Sethi; Nirja Kaka; Swati Mishra; Neil Patel; Asad Ullah Wasim; Saumya S Joshi; Kenisha Shah
Journal:  Cureus       Date:  2021-12-21

8.  Association of HCV with diabetes mellitus: an Egyptian case-control study.

Authors:  Eman I Elhawary; Gamal F Mahmoud; Mai A El-Daly; Fatma A Mekky; Gamal G Esmat; Mohamed Abdel-Hamid
Journal:  Virol J       Date:  2011-07-26       Impact factor: 4.099

9.  Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?

Authors:  Thazhath Mavali Ramachandran; Aninchent Harayil Rajan Rajneesh; George Sarin Zacharia; Rajendran P Adarsh
Journal:  J Clin Diagn Res       Date:  2017-09-01

10.  Calprotectin in viral systemic infections-COVID-19 versus hepatitis C virus.

Authors:  Letitia Toma; Mihai Dodot; Anca Zgura; Nicolae Bacalbasa; Andrei Silaghi; Razvan Simu; Teodora Isac; Adriana Mercan-Stanciu
Journal:  Clin Exp Med       Date:  2021-07-12       Impact factor: 5.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.